Bullfrog AI (BFRG) Competitors

$2.87

-0.12 (-4.01%)

(As of 11/28/2023 ET)

Today's Range: $2.87
▼
$2.99
50-Day Range: $2.69
▼
$3.55
52-Week Range: $2.47
▼
$9.50

Volume: 32,644 shs
Average Volume: 1.22 million shs
Market Capitalization: $17.48 million

P/E Ratio: N/A
Dividend Yield: N/A
Price Target: N/A

BFRG vs. DRRX, QLI, CALC, EQ, UNCY, CBIO, SYBX, FBIO, AKTX, and COCP

Should you be buying Bullfrog AI stock or one of its competitors? The main competitors of Bullfrog AI include DURECT (DRRX), Qilian International Holding Group (QLI), CalciMedica (CALC), Equillium (EQ), Unicycive Therapeutics (UNCY), Catalyst Biosciences (CBIO), Synlogic (SYBX), Fortress Biotech (FBIO), Akari Therapeutics (AKTX), and Cocrystal Pharma (COCP). These companies are all part of the "pharmaceutical preparations" industry.

Bullfrog AI vs.

Bullfrog AI (NASDAQ:BFRG) and DURECT (NASDAQ:DRRX) are both small-cap medical companies, but which is the superior investment? We will contrast the two companies based on the strength of their risk, earnings, valuation, media sentiment, analyst recommendations, institutional ownership, community ranking, profitability and dividends.

: DURECT has a consensus target price of $34.25, indicating a potential upside of 5,397.59%. Given DURECT's higher possible upside, analysts plainly believe DURECT is more favorable than Bullfrog AI.
Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Bullfrog AI
0 Sell rating(s)
0 Hold rating(s)

0 Buy rating(s)

0 Strong Buy rating(s)
N/A
DURECT
0 Sell rating(s)

2 Hold rating(s)

2 Buy rating(s)

0 Strong Buy rating(s)
2.50
: Bullfrog AI has higher earnings, but lower revenue than DURECT.
Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
Bullfrog AI $10K 1,747.83 -$2.80M N/A N/A
DURECT $19.28M 0.96 -$35.33M -$1.58 -0.39
: Bullfrog AI has a net margin of 0.00% compared to DURECT's net margin of -398.65%. Bullfrog AI's return on equity of -185.78% beat DURECT's return on equity.
Company Net Margins Return on Equity Return on Assets
Bullfrog AI N/A -185.78% -114.76%
DURECT -398.65% -289.99% -78.74%
: In the previous week, Bullfrog AI and Bullfrog AI both had 2 articles in the media. Bullfrog AI's average media sentiment score of 1.87 beat DURECT's score of 0.77 indicating that Bullfrog AI is being referred to more favorably in the media.
Company Overall Sentiment
Bullfrog AI Very Positive
DURECT Positive
: DURECT received 315 more outperform votes than Bullfrog AI when rated by MarketBeat users.
Company Underperform Outperform
Bullfrog AI N/A N/A
DURECT Outperform Votes
315
66.88%
Underperform Votes
156
33.12%
: 0.1% of Bullfrog AI shares are owned by institutional investors. Comparatively, 32.8% of DURECT shares are owned by institutional investors. 4.3% of DURECT shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Bullfrog AI	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	N/A
DURECT	0 Sell rating(s)	2 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.50

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Bullfrog AI	$10K	1,747.83	-$2.80M	N/A	N/A
DURECT	$19.28M	0.96	-$35.33M	-$1.58	-0.39

Company	Net Margins	Return on Equity	Return on Assets
Bullfrog AI	N/A	-185.78%	-114.76%
DURECT	-398.65%	-289.99%	-78.74%

Company	Overall Sentiment
Bullfrog AI	Very Positive
DURECT	Positive

Company	Underperform	Outperform
Bullfrog AI	N/A	N/A
DURECT	Outperform Votes 315 66.88%	Underperform Votes 156 33.12%

Summary

DURECT beats Bullfrog AI on 7 of the 12 factors compared between the two stocks.

Get Bullfrog AI News Delivered to You Automatically

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding BFRG and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

BFRG vs. The Competition

Export to Excel

Metric	Bullfrog AI	Pharmaceutical Industry	Medical Sector	NASDAQ Exchange
Market Cap	$17.48M	$5.92B	$4.49B	$6.70B
Dividend Yield	N/A	3.13%	2.96%	6.96%
P/E Ratio	N/A	13.39	139.22	13.53
Price / Sales	1,747.83	268.48	2,514.32	76.10
Price / Cash	N/A	15.42	21.61	22.84
Price / Book	N/A	3.81	3.74	4.47
Net Income	-$2.80M	$204.16M	$122.41M	$176.27M
7 Day Performance	-5.90%	1.42%	1.06%	1.15%
1 Month Performance	2.14%	9.84%	13.45%	9.57%
1 Year Performance	N/A	4.01%	5.54%	2.60%

Bullfrog AI Competitors List

Export to Excel

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
DRRX DURECT	2.0902 of 5 stars	$0.63 -3.1%	$34.25 +5,328.8%	-86.5%	$18.82M	$19.28M	-0.40	72	Gap Down
QLI Qilian International Holding Group	0 of 5 stars	$0.50 +11.1%	N/A	-63.8%	$17.87M	$61.93M	0.00	345	News Coverage Gap Up
CALC CalciMedica	2.6229 of 5 stars	$3.09 -1.0%	$14.00 +353.1%	N/A	$17.57M	N/A	0.00	14	Positive News Gap Down
EQ Equillium	2.2759 of 5 stars	$0.50 flat	$5.33 +967.6%	-69.7%	$17.52M	$42.63M	-2.08	47	Short Interest ↑ Positive News
UNCY Unicycive Therapeutics	1.9458 of 5 stars	$0.50 -3.8%	$10.83 +2,058.0%	-19.7%	$17.45M	$1.63M	-0.29	12	Short Interest ↑
CBIO Catalyst Biosciences	1.7635 of 5 stars	$0.51 -2.6%	N/A	-7.1%	$19.42M	$790,000.00	-0.37	7	Gap Up
SYBX Synlogic	2.479 of 5 stars	$2.12 +1.9%	$82.50 +3,791.5%	-76.0%	$19.48M	$1.18M	-0.17	72	Short Interest ↓ Positive News
FBIO Fortress Biotech	2.635 of 5 stars	$2.20 -21.4%	$75.00 +3,309.1%	-81.3%	$19.53M	$62.75M	-0.18	187	Short Interest ↑ Positive News High Trading Volume
AKTX Akari Therapeutics	2.1283 of 5 stars	$3.05 -6.7%	$30.00 +883.5%	-74.8%	$17.24M	N/A	0.00	15	Short Interest ↓ News Coverage
COCP Cocrystal Pharma	2.3107 of 5 stars	$1.63 -0.6%	$12.00 +636.2%	-30.0%	$16.58M	$2.01M	-0.78	12	Short Interest ↑ Gap Up

Related Companies and Tools

Related Companies:

Top 10 Stock Comparisons

This page (NASDAQ:BFRG) was last updated on 11/29/2023 by MarketBeat.com Staff

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial

Bullfrog AI (BFRG) Competitors

BFRG vs. DRRX, QLI, CALC, EQ, UNCY, CBIO, SYBX, FBIO, AKTX, and COCP

Bullfrog AI vs.

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

BFRG vs. The Competition

Bullfrog AI Competitors List

Related Companies and Tools

About MarketBeat

Popular Tools

Financial Calendars

Terms & Info